Director Martin J. Joyce will not stand for re-election at 2026 annual meeting

Aldeyra Therapeutics, Inc.

Martin J. Joyce notified Aldeyra on April 20, 2026 of his decision not to stand for re-election.
His term will expire at the upcoming 2026 annual meeting of stockholders.
The decision was not the result of any disagreement with Aldeyra.

item 5.02

Aldeyra Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-164198

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.